Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track CING with free AI briefings, catalyst countdowns, and dilution alerts.

CING

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$28.4M Cash on Hand

13.3mo Cash Runway

16.8% Short Interest

🧪 Upcoming Trial Catalysts

2026-02-17 · fda_pdufa — PDUFA Date Mentioned in 8-K Filing
2025-11-13 · fda_pdufa — PDUFA Date Mentioned in 8-K Filing
2025-11-10 · fda_pdufa — PDUFA Date Mentioned in 8-K Filing
2025-10-14 · fda_pdufa — PDUFA Date Mentioned in 8-K Filing
2024-12-21 · Phase 1 — Results Expected — In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)
2024-02-29 · Phase 3 — Results Expected — Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

📊 Drug Pipeline

Drug	Indication	Phase	Status
CTx-1301 - Dexmethylphenidate 18.75mg	ADHD	PHASE3	SUSPENDED
CTx-1301-Dexmethylphenidate 37.5 mg (ran	ADHD	PHASE3	COMPLETED
CTx-1301-Dexmethylphenidate 25mg (random	ADHD	PHASE3	COMPLETED
CTx-1301-Dexmethylphenidate 18.75mg (ran	ADHD	PHASE3	COMPLETED
CTx-1301-Dexmethylphenidate 12.5 mg (tit	ADHD	PHASE3	COMPLETED
CTx-1301 - Dexmethylphenidate 6.25mg	ADHD	PHASE3	SUSPENDED
CTx-1301 - Dexmethylphenidate 50mg	ADHD	PHASE3	COMPLETED
CTx-1301 - Dexmethylphenidate 37.5mg	ADHD	PHASE3	COMPLETED
CTx-1301 - Dexmethylphenidate 31.25mg	ADHD	PHASE3	SUSPENDED
CTx-1301 - Dexmethylphenidate 25mg	ADHD	PHASE3	COMPLETED

💰 Cash Runway & Dilution Risk

CING holds $28.4M in cash and burns about $6.4M/quarter from operations, giving an estimated runway of 13.3 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for CING free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-07-20	Silva Raul R.	Purchase	$0
2026-07-20	Silva Raul R.	Purchase	$0
2026-07-20	Werth Peter J.	Purchase	$0
2026-07-20	Callahan Jennifer L.	Purchase	$0
2026-07-20	Callahan Jennifer L.	Purchase	$0

Get the full CING picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for CING and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z